Comparative RNAi Screening Reveals Host Factors Involved in Enterovirus Infection of Polarized Endothelial Monolayers  by Coyne, Carolyn B. et al.
Cell Host & Microbe
ResourceComparative RNAi Screening Reveals
Host Factors Involved in Enterovirus
Infection of Polarized Endothelial Monolayers
Carolyn B. Coyne,1,* Rebecca Bozym,1 Stefanie A. Morosky,1 Sheri L. Hanna,3 Amitava Mukherjee,1 Matthew Tudor,4
Kwang Sik Kim,2 and Sara Cherry3,*
1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA
2Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
3Department of Microbiology, Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, PA 19104, USA
4Philadelphia, PA 19146, USA
*Correspondence: coynec2@pitt.edu (C.B.C.), cherrys@mail.med.upenn.edu (S.C.)
DOI 10.1016/j.chom.2011.01.001SUMMARY
Enteroviruses, including coxsackievirus B (CVB) and
poliovirus (PV), can access the CNS through the
blood brain barrier (BBB) endothelium to cause
aseptic meningitis. To identify cellular components
required for CVB and PV infection of human brain
microvascular endothelial cells, an in vitro BBB
model, we performed comparative RNAi screens
and identified 117 genes that influenced infection.
Whereas a large proportion of genes whose deple-
tion enhanced infection (17 of 22) were broadly anti-
enteroviral, only 46 of the 95 genes whose depletion
inhibited infection were required by both CVB and PV
and included components of cell signaling pathways
such as adenylate cyclases. Downregulation of
genes including Rab GTPases, Src tyrosine kinases,
and tyrosine phosphatases displayed specificity in
their requirement for either CVB or PV infection.
These findings highlight the pathways hijacked by
enteroviruses for entry and replication in the BBB
endothelium, a specialized and clinically relevant
cell type for these viruses.
INTRODUCTION
Many viruses exhibit specific tropism for polarized epithelia and/
or endothelia to promote host invasion and/or facilitate spread.
Despite this, little is known regarding the host cell molecules
that facilitate infection of polarized cells andwhether thesemole-
cules are specific to polarized cells or are specific between the
epithelium and endothelium. Enteroviruses, which belong to
the Picornaviridae family, are a large family of nonenveloped
single-stranded RNA viruses of 8 kb in length (Pallansch and
Roos, 2001). Enteroviruses generally utilize some form of endo-
cytosis to gain entry into the host cell cytoplasm and once inter-
nalized, undergo uncoating and subsequent translation of the
single open reading frame of the incoming viral RNA via an
internal ribosome entry site. Picornaviruses remodel cellular70 Cell Host & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inorganelles and block host cell translation to allow for high levels
of viral replication. The structural proteins assemble with the viral
genomic RNA and exit the cell via the destruction of the host cell
membranes. These viruses initiate infection in the highly polar-
ized intestinal epithelium before spreading to a variety of polar-
ized and nonpolarized cell types during the course of an infec-
tion. Secondary sites of infection can include the spinal cord
and brain, the heart, or the skin and play an important role in
the pathogenic outcome of infection (Morens and Pallansch,
1995).
Our previous studies have established that two enteroviruses,
coxsackievirus B (CVB), and poliovirus (PV), enter polarized cells
by endocytic mechanisms that require activation of specific
intracellular signaling molecules (Coyne and Bergelson, 2006;
Coyne et al., 2007a; Coyne et al., 2007b). These studies have
highlighted the specificity of intracellular signals required for
virus entry—whereas CVB induces a cascade of tyrosine
kinase-mediated signals to enter the epithelium (Coyne and
Bergelson, 2006), PV entry into polarized endothelia requires
the activation of tyrosine phosphatases (Coyne et al., 2007a).
Although these studies highlight the divergent signaling mole-
cules that facilitate CVB and PV entry into polarized cells, it
remains unclear if there are common host factors that mediate
infection by these related viruses in the same cell type.
The use of RNA interference (RNAi) screens have extended our
knowledge of the complex interplay between a virus and host
and have implicated a wide variety of cellular factors required
for infection of a number of viruses (Brass et al., 2008; Cherry
et al., 2006; Hao et al., 2008; Krishnan et al., 2008; Pelkmans
et al., 2005; Sessions et al., 2009; Tai et al., 2009). Although these
studies identified host factors required for viral infection, they
were conducted in nonpolarized cell types that may not mimic
the in vivo cell types targeted by these pathogens. As enterovi-
ruses are commonly associated with neurological disease and
are the major etiological agents associated with aseptic menin-
gitis in adults and children (Morens and Pallansch, 1995), under-
standing the host factors required for infection of the blood-brain
barrier (BBB), a polarized endothelium, will allow us to dissect
the host cell factors that may regulate enterovirus infection of
the central nervous system (CNS).
To overcome these limitations to our understanding of entero-
virus infection of the polarized endothelium, we performed RNAic.
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human brain microvascular endothelial cells (HBMECs), an
immortalized cell line that replicates many of the functional and
morphologic characteristics of the BBB (Stins et al., 2001), to
identify factors that impact enterovirus infection. We performed
the screen using both CVB and PV to identify the host factors
co-opted by each virus and to determine if there are commona-
lites to the host factor requirements. This study sheds light on
genes in polarized endothelial cells that control enterovirus infec-
tion and highlights many host cell factors that mediate infection
of CVB and PV in this specialized cell type.
RESULTS
RNAi Screening in HBMECs
To study the early steps in the infection cycle, we developed
a single-round high-content assay (schematic, Figure 1A). To
this end, the Ambion Druggable Genome library (5492 genes)
containing pooled small interfering RNAs (siRNAs; three
siRNAs/gene) was arrayed in collagen-coated 384-well plates,
reverse transfected into HBMECs, and 48 hr posttransfection
infected with either CVB (3 PFU/cell) or PV (1 PFU/cell). The cells
were fixed and stained for the viral VP1 antigen (an enterovirus
capsid protein) 14 hr postinfection (p.i.) and counterstained for
nuclei. Automated microscopy and image analysis was used to
calculate the total number of cells per well and the percentage
of infected cells. These metrics were used to identify candidate
genes that modulated infection by a robust Z score of >2
or <2 (which approximates a >2 standard deviation difference
from the mean; >50% difference in virus infection) in duplicate
screens (p < 0.001; Figures S1Ai and S1Aii available online).
Toxic siRNAs were excluded based upon decreased cell
viability as measured by a robust Z score <2 in duplicate
screens (>30%decrease in cell number, Figure S1Aiii). As a posi-
tive control, siRNAs against coxsackievirus and adenovirus
Receptor (CAR) (Coyne and Bergelson, 2006) or poliovirus
receptor (PVR) (Coyne et al., 2007a) were included in three wells
of each plate and were positively identified (Figure S1Aiv). The
library contained both CAR and PVR siRNAs, which were also
positively identified in the screen (Figure S1Aiv).
We identified three classes of factors by RNAi screening—
those that specifically modulated CVB infection or PV infection
and those that impacted both viruses. Among these genes
were 31 positive and 144 negative regulators of infection for
CVB infection and 65 positive and 155 negative regulators for
PV infection (Table S1, part A). To confirm the hits identified in
our primary screen, we screened three unique and independent
siRNAs targeting each gene (QIAGEN) identified in the primary
screen (310 total genes). We identified hits as those genes in
which at least one additional siRNA displayed a significant
impact on infection (Z score ± 1.5, change in infection of
>30%, p < 0.009). Of the 117 genes that we validated (a confir-
mation rate of 38%), 100 had multiple siRNAs that significantly
affected infection, while in only 17 cases did only one QIAGEN
siRNA impact infection (Table S1, part B). (A complete list of
genes that were not verified by secondary screening can be
found in Table S1, part C).
Using this screening strategy, we validated genes in the
three classes—those that specifically modulated CVB infectionCell(31 genes) or PV infection (23 genes) and those that were
required by both viruses (63 genes) (Figure 1B and Table S1,
part B). Of the genes identified that were involved in regulating
infection of both viruses, 46 genes promoted infection while 17
functioned in an antiviral capacity (Figure 1C). In contrast, genes
that were specific to either CVB or PV were largely found to be
required for promoting rather than restricting infection (Fig-
ure 1C). There was a substantial overlap in the genes that were
required by both viruses (p < 109), suggesting that these two
related enteroviruses use many of the same factors to replicate
in HBMECs.
Molecular function analysis revealed that the genes required
for CVB infection were enriched in the following pathways: cell
signaling, molecular transport, cell-cell signaling and interaction,
cell cycle, and cell death, among others (Figure 1D and Fig-
ure S1Bi). Genes involved in regulating PV infection were
enriched in lipid metabolism, cell death, cell growth and prolifer-
ation, and cell cycle, among others (Figure 1E and Figure S1Bii).
Genes that were involved in regulating infection by both
viruses were enriched in cell death, cellular development, cell
morphology, cell-cell signaling and interaction, and cellular
movement, among others (Figure 1F and Figure S1Biii).
Protein network analysis revealed interactions between genes
identified as regulators of CVB and PV infection in cell death and
cell signaling pathways and cell growth and development,
respectively (Figures S1C and S1D). Pathway analysis also
revealed an enrichment of genes associated with the regulation
of intracellular calcium (Cai
2+) signaling or which depend on
alterations in Cai
2+ for their activation and/or function specifically
involved in the regulation of CVB infection (Figure S1E).
Furthermore, microarray analysis of a previous study using
HBMECs revealed that 68 of these genes were expressed as
monitored using an Affimetrix platform (Tripathi et al., 2009)
(Table S1, part B).
Akt and MAPK Family Members Restrict Enterovirus
Replication in HBMECs
We identified 22 genes whose depletion upregulated infection of
CVB, PV, or both. Of these genes, 17 were broadly antiviral
against both CVB and PV. Because of the high degree of overlap
between immune-related factors involved in regulating CVB and
PV infection, we characterized a subset of these potential innate
immune candidates that restricted both viruses. Among these
candidates, we identified Akt1 and Akt2, two of the three family
members of the Akt family as genes whose knockdown of
multiple independent validated siRNAs led to a significant
enhancement of CVB and PV infection in HBMECs (Figure 2A
and Table S1, part B). We further studied the role of these Akt
candidates using a number of different approaches. First, we
found that overexpression of a dominant-negative mutant of
Akt1 (Akt1K179M) or Akt2 (Akt2K181M) increased enteroviral infec-
tion (Figure 2B). Next, we used pharmacological inactivation of
Akt using the Akt1/Akt2 inhibitor SH-6 and found that this led
to increased enteroviral infection (data not shown). To determine
whether the requirement for Akt in antiviral defense occurs via
the canonical Akt-mTOR signaling pathway we treated cells
with rapamycin, an inhibitor of TOR and found that indeed infec-
tion was increased under these conditions (Figure 2B). Further-
more, we found that rapamycin and Akt2 siRNA also significantlyHost & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inc. 71
Figure 1. RNAi Screening
(A) Schematic of screening strategy.
(B) Venn diagram highlighting the degree of overlap between hits validated in CVB and PV screens.
(C) Distribution of genes identified whose downregulation increased (green) or decreased (red) virus replication and were either specific for CVB or PV or were
involved in regulating both viruses.
(D–F) Pie charts showing the frequency of functional groups (curated by Ingenuity Pathway Analysis) fromCVB and PV screens. Shown in (D) and (E) are pathways
curated from genes with specific effects on either CVB (D) or PV (E) replication. Shown in (F) are pathways curated from genes whose downregulation modulated
both CVB and PV infection. Categories that are overrepresented (p < 0.001) are shown.
See also Figures S1A–S1E and Table S1, parts A–D.
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Figure 2. Akts, MAPKs Restrict CVB and PV Infection
(A) Enhanced replication in HBMECs transfected with Akt1 and Akt2, but not Akt3, siRNAs compared to an siRNA that had no effect on viral replication.
(B) The percentage of infected CVB- or PV-infected HBMECs (normalized to no inhibitor or wild-type controls) in cells transfected with either dominant-negative
Akt1 or Akt2, or treated with rapamycin.
(C) Enhanced replication in HBMECs transfected with MAP3K4, MAP3K1, and p21 Ras GAP siRNAs compared to an siRNA which had no effect on viral repli-
cation.
(D) Shown are the percentages of CVB- or PV-infected cells (normalized to no inhibitor or wild-type controls) in HBMECs transfected with either dominant-nega-
tive MAP3K4 or treated with FR180204.
(E) Enhanced replication in HBMECs transfected with IRAK1 and TLR8, but not TLR7, siRNAs compared to an siRNA which had no effect on viral replication.
(F) Shown are the percentage of CVB- or PV-infected cells (normalized to control plasmid [pcDNA]) in HBMECs transfected with either dominant-negative TLR8
(TLR8DTIR), IRAK1 (IRAK1DN), or MyD88 (MyD88DN).
For (B), (D), and (F), data are represented as mean ± SD; *p < 0.05. Shown in white text are the Z score (bottom left) and percent infection (bottom right) from the
field displayed. Green, VP1; blue, DAPI. See also Figures S2A and S2B and Tables S2 and S4.
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results are not a consequence of cell immortalization (Figures
S2Ai and S2Aii).
We also identified the MAPK pathway as a negative regulator
of enterovirus replication as downregulation of both MAP3K4
(also known as MEKK4) and MAPK1 (also known as ERK1) by
multiple independent validated siRNAs significantly increased
CVB and PV infection in HBMECs (Figure 2C and Table S1,
part B). We further studied the role of this pathway by expressionCellof a kinase-defectivemutant ofMAP3K4 (MAP3K4K1361M) and by
treatment of cells with a specific ERK1/2 inhibitor (FR180204),
both of which enhanced CVB and PV infection (Figure 2F).
As our initial screen targeted a polarized cell type, we were
interested in whether the factors identified in the primary screen
that functioned to restrict enterovirus replication were specific to
polarized cells or whether these genes would also be involved in
restricting infection in a non-polarized cell type. To that end, we
tested the role of Akt1, Akt2, MAP3K4, and MAPK1 using theHost & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inc. 73
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found that knockdown of all four genes significantly increased
CVB replication in U2OS cells (Figure S2Bi and Table S2).
Furthermore, we found that pharmacological inhibitors of Akt
(SH-6), ERKI/II (FR180204), and mTOR (rapamycin) as well as
dominant-negative mutants of Akt2 andMAP3K4 also enhanced
CVB replication in U2OS cells (Figure S2Bii). Taken together,
these data show that Akt and MAPK signaling restricts entero-
virus infection across cell types of both nonpolarized and polar-
ized origins andmay provide insights into the signaling pathways
that restrict enterovirus infection in non-immune cells.
TLR8 Restrict CVB and PV Replication in HBMECs
The induction of type I IFN signaling is essential for the restriction
of enterovirus infections, as evidenced by enhanced CVB-
induced lethality in type I IFN receptor (IFN-a/b R)-null mice
(Wessely et al., 2001), increased susceptibility to CVB infection
in IFNb-deficient mice (Deonarain et al., 2004), and increased
lethality and CNS entry of PV in IFN-a/b R-null mice (Lancaster
and Pfeiffer, 2010). We identified toll-like receptor 8 (TLR8)
and its downstream signaling adaptor interleukin-1 receptor-
associated kinase 1 (IRAK1) with multiple independent siRNAs
as antiviral host genes against CVB and PV in HBMECs (Fig-
ure 2E and Table S1B). In contrast, downregulation of TLR7,
which is closely related to TLR8, had no effect (Figure 2E). To
further study the role for TLR8 and IRAK1, we overexpressed
dominant-negative mutants of TLR8 (TLR8DTIR), IRAK1
(IRAK1DN), or the TLR8 adaptor Myeloid differentiation primary
response gene (88) (MyD88) and determined the effects of this
expression on CVB and PV infection of HBMECs. Consistent
with our screening results, we found that overexpression of
dominant-negative mutants of TLR8, IRAK1, or MyD88 all led
to an enhancement of CVB and PV replication in HBMECs
(Figure 2F). Similar to our findings with Akts and MAPKs (Fig-
ure S2Bi), we also found that RNAi-mediated silencing of
IRAK1 and TLR8 enhanced CVB replication in non-polarized
U2OS cells (Figure S2Biii and Table S2). Taken together, these
data implicate TLR8 as playing a prominent role in the detection
of enterovirus infections in the BBB and perhaps in other nonpo-
larized cell types.
Adenylate Cyclases Mediate CVB and PV Infection
of HBMECs
In contrast to the cellular factors described above that played
antiviral roles against both viruses, we identified a number of
factors whose depletion significantly impaired replication of
both CVB and PV. Among these factors were several members
of the adenylate cyclase (ADCY) family. ADCYs catalyze the
conversion of ATP into cAMP, an important second messenger
that regulates a diverse array of cellular process and often
converges of cAMP dependent protein kinase (PKA) activation.
ADCYs can be categorized into four groups (classified as A–D)
that differ in their upstream modulators. We identified ADCY
family members in groups A–C, including ADCY1, ADCY4,
ADCY6, and ADCY7 with multiple independent siRNAs which
were each required for infection by CVB and PV (Figure 3A and
Table S2). We also identified a putative adenylate kinase-like
protein (C9orf98) with multiple siRNAs, which was the strongest
candidate gene in our primary CVB screen (Figure 3A and Table74 Cell Host & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier InS1, part B). We used an ADCY inhibitor to confirm a role for
ADCYs in facilitating CVB and PV replication and to dissect at
which step ADCYs may be required for viral replication. Treat-
ment of cells with the broad spectrum ADCY inhibitor 2,5-
dideoxy-adenosine (DDA) led to a significant dose-dependent
inhibition of both CVB and PV replication in HBMECs, consistent
with our RNAi screen findings (Figures 3B–3D). Mechanistically,
the role of ADCYs seemed to occur early in infection as DDA lost
its inhibitory effect when added at early time post-infection
(2–3 hr p.i.) (Figures 3B and 3C).
If ADCYs play a role mediating enterovirus infection, then
levels of cAMP should increase during the course of infection.
Indeed, we found that cAMP levels increased significantly in
HBMECs infected with CVB or PV within 2 hr p.i. (which corre-
sponds to the time that ADCY activity is required [Figure 3E]).
Since PKA is a major downstream effector of ADCYs and is
dependent upon cAMP for its activation, we tested whether
PKA was important for enteroviral infection. We found that
CVB and PV infection were attenuated when cells were treated
with H89, a potent selective inhibitor of PKA (Figures 3B
and 3C). Together, these data implicate a prominent role for
ADCY-dependent cAMP generation in enterovirus infection of
HBMECs, and likely at an early step in the replication cycle.
cAMP Signaling Mediates CREB-Dependent
Transcription During CVB and PV Infection of HBMECs
As we observed a role for ADCYs, cAMP, and PKA signaling in
CVB and PV infection of HBMECs, we next determined the
mechanism(s) by which these signaling events regulated infec-
tion. cAMP-dependent activation of PKA has been shown
to result in activation of gene transcription via the transcrip-
tion factor cAMP-response element (CRE)-binding protein
(CREB). CREB is directly phosphorylated by PKA at Serine133
(pSer133) and, once activated, binds to the nuclear factor
CREB binding protein (CREBBP), or a closely related protein
p300, to induce gene transcription. Pathway analysis revealed
several components of CREB-dependent transcription as being
required for CVB and PV infection of HBMEB (p < 105) (data
not shown). These included CREBBP, RNA polymerase II
(POLR2K), and the transcription factor STAT1 (Figure 4A and
Table S1, part B).
We found that CVB and PV infection of HBMECs induced
significant enhancement of CRE-mediated gene transcription
as assessed by CRE-luciferase reporter assays (Figure 4B).
This enhancement required the activity of ADCYs as treatment
of cells with the ADCY inhibitor DDA inhibited CVB- and PV-
induced CRE activation (Figure 4B). We also found CVB- and
PV-induced CRE activation in human embryonic kidney cells
(HEK293) (Figure S3).
Furthermore, using immunofluorescence microscopy with an
antibody specific to activated (pSer133) CREB, we observed
significant increases in CREB activation in CVB- and PV-infected
HBMECs (Figure 4C). Increased nuclear staining for pSer133
CREB was evident within 2 hr p.i. in both CVB- and PV-infected
HBMECs and persisted until 3 hr p.i. (Figures 4C and 4D).
This is prior to the appearance of newly replicated viral RNA
or protein (data not shown). However, at late stages of viral
replication (>5 hr p.i.), there was a marked decrease in pSer133
CREB and a corresponding decrease in overall CREB levelsc.
Figure 3. Adenylate Cyclases Are Required for CVB and PV Replication
(A) Decreased CVB and PV replication in HBMECs transfected with adenylate cyclase 1 (ADCY1), ADCY4, ADCY6, ADCY7, and C9orf98 siRNAs compared to an
siRNA that had no effect on viral replication. Shown in white text are the Z score (bottom left) and percent infection (bottom right) from the field displayed. Green,
VP1; blue, DAPI.
(B and C) CVB (B) and PV (C) infection of HBMECs is diminished when cells are pretreated with DDA or H89, but not when either inhibitor is added at >2 hr post-
infection (p.i.).
(D) Dose-dependent inhibition of CVB replication in HBMECs treated with the indicated concentration of DDA.
(E) Elevated cAMP levels in HBMECs infected with CVB or PV for the indicated times.
For (B–E), data are shown as mean ± SD; *p < 0.05, **p < 0.001. See also Table S4.
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cAMP generation induces CREB-mediated gene transcription
to facilitate enterovirus replication and that there is temporal
control as the system is shut off during later times post infection.
Endosomal Trafficking of Internalized CVB and PV
Particles Is Regulated by LMTK2
Another common factor required for CVB and PV infection of
HBMECs and identified by our RNAi screening (with multiple
independent siRNAs) was lemur tyrosine kinase 2 (LMTK2) (Fig-
ure 5A and Table S1, part B). While microarray data suggested
that LMTK2 was not expressed in HBMECs, we detected protein
expression by immunoblot that was reduced upon siRNA-medi-
ated knockdown (Figure 5D and Table S1, part B). LMTK2 has
been shown to associate with the actin-based motor protein
myosin IV and regulate endosomal trafficking events (Chibalina
et al., 2007; Inoue et al., 2008). Because of the association
between LMTK2 and vesicular trafficking, we investigatedCellwhether this kinase might facilitate the cytoplasmic trafficking
of CVB and PV upon their internalization into HBMECs.
Consistent with its role in vesicular trafficking, we found that
RNAi-mediated silencing of LMTK2 expression altered the
morphology of endosomal compartments within HBMECs as
assessed by immunoflorescence microscopy for early endo-
some antigen-1 (EEA1) and Rab5 GTPase (Figures 5B and 5D).
Moreover, whereas internalized CVB and PV particles reached
a perinuclear compartment within 60 min (CVB) or 2.5 hr (PV)
p.i. in HBMECs transfected with a control siRNA, we found
that LMTK2 silencing induced the appearance of mislocalized
CVB- and PV-containing vesicles within the cytoplasm that failed
to traffic to a perinuclear compartment (Figures 5C and 5D).
In contrast, we found that LMTK2 siRNA had no effect on CVB
or PV infection of polarized intestinal Caco-2 cells, indicating
that its function in intracellular trafficking of internalized CVB
and PV particles may be specific to polarized endothelium
(Figure 5E).Host & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inc. 75
Figure 4. CREB-Dependent Transcription Is Involved in CVB and PV Replication in HBMECs
(A) Decreased CVB and PV replication in HBMECs transfected with CREBBP, RNA polymerase II (POLR2K), or STAT1 siRNAs compared to an siRNA which had
no effect on viral replication. Shown in white text are the Z score (bottom left) and percent infection (bottom right) from the field displayed. Green, VP1; blue, DAPI.
(B) Activation of CRE-dependent transcription as assessed by luciferase assay in CVB- or PV-infected HBMECs either without inhibitor (NoI) or in the presence of
DDA. Data are presented as mean ± SD; *p < 0.05 and are displayed as fold change over uninfected (NoV) controls.
(C) Immunofluoresence microscopy for total CREB (magenta), activated pS133 CREB (green), VP1 (red), and DAPI-stained nuclei (blue) in HBMECs infected with
CVB (left) or PV (right) for the indicated times.
(D and E) Quantification of nuclear localized pSer133-CREB (D) and total CREB (E) in uninfected (NoV) cells or in cells infected with CVB or PV for the indicated
times.
For (B), (D), and (E), data are shown as mean ± SD; *p < 0.05. See also Figure S3 and Table S4.
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HBMECs
In addition to the genes that facilitated infection of both CVB and
PV, we also identified genes that specifically facilitated CVB or
PV infection. This included the Rab GTPase Rab17 as a specific
regulator of CVB, but not PV, infection (Figure 6A and Table S1,
part B). Rab GTPases are important regulators of vesicular traf-
ficking and often display specificity with regard to their endoso-
mal localization and functioning (Zerial and McBride, 2001).
Rab17 is a polarized cell-specific Rab GTPase family member
known to regulate apical vesicular trafficking in polarized cells76 Cell Host & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier In(Hunziker and Peters, 1998; Lu¨tcke et al., 1993). While microar-
ray analysis suggested that Rab17 was not expressed in
HBMECs, we found that it is expressed at low levels (Table S1,
part B, and data not shown). To verify that the phenotype was
due to depletion of Rab17 and not an off-target effect, we gener-
ated a Rab17 allele that was resistant to siRNA-mediated
silencing (siRes). We found that indeed we could rescue the
defect in infection mediated by siRNA against Rab17 by expres-
sion of the resistant Rab17 allele (Figure 6B).
We further explored a role for Rab17 in CVB infection of
HBMECs by expressing either a dominant-negative (Rab17N132I)c.
Figure 5. LMTK2 Regulated Endosomal Trafficking of CVB and PV
(A) Decreased CVB and PV replication in HBMECs transfected with LMTK2
siRNA compared to an siRNA which had no effect on viral replication. Shown
in white text are the Z score (bottom left) and percent infection (bottom right)
from the field displayed. Green, VP1; blue, DAPI.
(B) Immunofluorescence microscopy for Rab5 GTPase (top) or early endo-
some antigen-1 (EAA1) (bottom) in HBMECs transfected with either a control
(scrambled, Con) or LMTK2 siRNA.
(C) Immunofluorescence microscopy for CVB (top) or PV (bottom) at the indi-
cated times in cells transfected with either a control (scrambled, Con) or
LMTK2 siRNA.
(D) Immunoblot for LMTK2 in HBMECs transfected with either control (siCon)
or LMTK2 (siLMTK2) siRNAs (GAPDH is included as a loading control).
(E) CVB and PV replication in either HBMECs or Caco-2 cells transfected with
controls or LMTK2 siRNAs. Data are presented as mean ± SD; *p < 0.05, and
are normalized to control siRNA-transfected cells.
See also Table S4.
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mutants significantly reduced CVB infection of HBMECs,
whereas PV infection was unaffected by either (Figure 6C and
data not shown). Furthermore, we found that internalized CVB
particles colocalized with Rab17 (Figure 6D). The role of Rab17
in CVB infection appears to be specific for HBMECs as neither
Rab17N132I nor Rab17Q77L mutants had any effect on CVB infec-
tion of Caco-2 cells (Figure 6E and data not shown).
Since Rab17 had no affect on PV infection, we reasoned that
there might be another Rab responsible for its entry and/or traf-
ficking. Therefore, we reanalyzed our primary RNAi screen data
and found that Rab34was the only other Rab to have a significant
effect on PV infection (and only did so with PV with a Z score
of 1.84, thus missing our cutoff [Table S3 contains a list of Z
scores of all Rab GTPases contained in our primary screen]).
Rab34 has been identified as playing a role in macropinocytosis
as well as trafficking within the Golgi (Goldenberg et al., 2007;
Sun et al., 2003). Therefore, we tested whether Rab34 played
a role in PV or CVB infection using secondary siRNAs and indeed
observed an effect on PV but not CVB infection (Figure 6A).
Furthermore, we found that overexpression of a dominant-nega-Celltive mutant of Rab34 (Rab34T66N) significantly impaired PV repli-
cation while having no effect on CVB infection of HBMECs
(Figure 6B). As a control, we also tested whether a dominant-
negative form of Rab 5 GTPase, which was not identified in our
RNAi screen, had any effect on CVB or PV infection (Figure 6A).
Consistent with our screen data, we found that dominant-nega-
tive Rab5 (Rab5S34N) had no effect on CVB or PV infection of
HBMECs (Figure 6B). Thus, while Rab5 and Rab34 GTPases
are required for uptake of CVB into Caco-2 cells (Coyne et al.,
2007b), they are dispensable for CVB infection HBMECs (Fig-
ure 6E). These findings implicate vesicular trafficking mediated
by specific RabGTPases as cell-type and enterovirus-specific
regulators of entry.
Unique Tyrosine Kinases and Phosphatases Control
CVB and PV Infection of HBMECs
One important consequence of receptor binding by viruses is the
activation of intracellular signaling molecules that regulate entry.
Our previous studies established a role for the Src family nonre-
ceptor kinase (SFK) member Fyn in mediating CVB entry into
Caco-2 cells (Coyne and Bergelson, 2006). Although the RNAi
library used in our screening included siRNAs targeting all 9
SFKs (including Fyn), Yes kinase was the only SFK member
identified as being required for infection by CVB in HBMECs
(Figure 7A and Table S1, part B). Interestingly, PV infection of
HBMECs was also independent of Yes kinase (and Fyn) but
instead required the expression of Lyn kinase (Figure 7A and
Table S1, part B).
We further explored the role for these SFKs in mediating CVB
and PV infection by using dominant negative kinases. We found
that expression of dominant-negative Yes kinase (YesK305M) led
to a significant inhibition of CVB infection of HBMECs while
having no effect on PV (Figure 7B). Likewise, expression of domi-
nant-negative Lyn kinase (LynY397F) led to a significant inhibition
of PV infection in HBMECs while having no effect on CVB (Fig-
ure 7B). These results confirm a specific role for both Yes and
Lyn kinases in the infection of HBMECs by CVB and PV, respec-
tively. We next assayed the kinetics of CVB- and PV-induced
SFK activation. We found that CVB induced the rapid activation
(<15 min p.i.) of SFKs in HBMECs (Figure 7C). In contrast, PV
infection did not lead to a significant induction of SFK activation
(Figure 7C). Our previous studies have shown that PV entry into
HBMECs occurs via a SFK independent mechanism and instead
requires the activity of tyrosine phosphatases (Coyne et al.,
2007a). Therefore, Lyn kinase likely plays a role in postentry
events associated with PV infection.
Tyrosine phosphatases function to tightly regulate a variety of
cellular processes in coordination with tyrosine kinase signaling.
In addition to the SFKsmentioned above, we identified a number
of protein tyrosine phosphatases (PTPs) by RNAi screening that
were involved in both CVB and PV infection, or specifically regu-
lated infection by either virus withmultiple siRNAs (Figure 7D and
Table S1, part B). Whereas nonreceptor PTPN2 was identified as
playing a role in CVB and PV replication, receptor PTPRF (LAR)
was involved in CVB infection and nonreceptor PTPN18 was
specifically required for PV infection of HBMECs (Figure 7D).
We studied the role for PTPs in regulating CVB and PV infection
of HBMECs by treating cells with a pan-PTP pharmacological
inhibitor. We found that replication of both CVB and PV wasHost & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inc. 77
Figure 6. Unique Rab GTPases Regulate CVB and
PV Infection
(A) CVB and PV replication are differentially impacted in
HBMECs transfected with Rab17 siRNA Rab34 siRNA or
an siRNA that had no effect on viral replication. Shown in
white text are the Z score (bottom left) and percent infec-
tion (bottom right) from the field displayed. Green, VP1;
blue, DAPI.
(B) HBMECs expressing dominant-negative or wild-type
forms of Rab5, Rab17, or Rab34 were infected with CVB
or PV. The graph shows the percent of transfected cells
expressing VP1 (mean ± SD for 2000 cells; *p < 0.05)
normalized to wild-type transfected controls.
(C) Immunofluorescence microscopy for CVB in HBMECs
transfected with wild-type EGFP-Rab17 at 60 min p.i.
(D) HBMECs transfected with control or Rab17 siRNAs
and cotransfected with either wild-type or siRNA-resistant
(siRes) EGFP-fused Rab17. Cells were infected with CVB
(48 hr after transfection) for 8 hr and the extent of viral
replication measured by immunofluorscence microscopy
(VP1/DAPI). In parallel, lysates were collected and immu-
noblotted for GFP (top) or GAPDH (bottom).
(E) HBMECs or Caco-2 cells expressing dominant-nega-
tive or wild-type forms of Rab5, Rab17, or Rab34 were
infected with CVB. The graph shows the number of trans-
fected cells expressing VP1 (mean ± SD for 2000 cells;
*p < 0.05) normalized to wild-type transfected controls.
See also Tables S3 and S4.
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inhibitor was added early in infection (Figure 7E), indicating
that they may function at or near the time of virus entry. Consis-
tent with this, we found robust activation of PTPs coincident with
CVB and PV entry into HBMECs as assessed by in vitro PTP acti-
vation assays (Figure 7F). These data implicate a role for PTPs in
addition to SFKs as important regulators of enterovirus infection
in the endothelium.
DISCUSSION
Enterovirus infections are commonly associated with neurolog-
ical disease. By performing a druggable genome RNAi screen
in a physiologically relevant cell type, we have identified
a number of host cell factors that facilitate infection of the endo-
thelium comprising the BBB, amajor component of host defense
in the CNS. By performing a comparative screenwith two entero-
viruses that are both associated with CNS-related pathology, we
identified two classes of genes—those that regulated infection
by both viruses versus those that were required in a virus-
specific context. These findings highlight the complexity associ-
ated with the cell signaling pathways hijacked by enteroviruses
to facilitate their entry and/or replication in the endothelium
and point to a role for several classes of molecules whose func-
tion in enterovirus infections were unknown.
Since off-target effects are a major issue in interpreting gene-
lists from RNAi screens we took a very conservative approach.
First, we used a stringent cutoff in the primary screen (p <
0.001). Second, rather than deconvoluting the original pools
used for screening, we ordered independent siRNAs from
another company. This should remove any biases associated
with siRNA prediction programs or peculiarities associated78 Cell Host & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inwith synthesis. The ‘‘reagent redundancy’’ argument states
that the more siRNAs that have the same phenotype the more
likely the phenotype is on target (Echeverri and Perrimon,
2006). By these criteria, 100 genes validated with at least two
of the three secondary siRNAs and 17 had one additional
QIAGEN siRNA validate (none of these had seed matches with
the original pools) in addition to the original primary screen
pool. Therefore, we had a validation rate of 38% for at least
two siRNAs which is similar to other published screens (Brass
et al., 2008). Furthermore, of the 930 secondary siRNAs we
screened, 62 were validated by QIAGEN to knockdown the
gene of interest. In fact, 77% of these ‘‘validated knockdown’’
siRNAs in our secondary screen scored as positives while only
22% of the ‘‘unvalidated’’ ones did suggesting that we are likely
missing some genes (false negatives) due to poor knockdown
(Table S1, parts B and C). Since off-target effects are difficult
to predict, each gene must be further characterized to be certain
that the RNAi phenotypes are due to the gene of interest and not
due to the targeting of another gene. To this end, for the 19
candidate genes discussed in more detail (Figures 2–7) we
used orthogonal assays (Table S4). We combined pharmacolog-
ical approaches with dominant negative mutants, cDNA rescue
and activity assays to show that for each gene we have multiple
independent lines of evidence that they are the bona fide targets
that play a role in infection. Interestingly, three quarters of these
validated genes impacted infection of both viruses, suggesting
that the restrictive mechanisms at play in these cells are panen-
teroviral. These included members of the Akt family, which have
been implicated in the regulation of CVB replication of nonpolar-
ized cells through a pathway that might involve host cell
apoptosis (Esfandiarei et al., 2004). Further studies are neces-
sary to clarify the mechanism by which Akt signaling is antiviral.c.
Figure 7. Tyrosine Kinases and Phosphatases Regulate CVB and PV Infection
(A) CVB infection of HBMECs is inhibited by downregulation of Yes kinase (but not Lyn kinase), whereas PV infection requires Lyn, but not Yes kinase. Shown are
HBMECs transfected with Yes or Lyn siRNAs compared to an siRNA that had no effect on viral replication. Shown in white text are the Z score (bottom left) and
percent infection (bottom right) from the field displayed. Green, VP1; blue, DAPI.
(B) HBMECs were transfected with dominant negative mutants of Yes (K308M) or Lyn (Y397F) kinases and infected with CVB or PV. Dashed line indicates the
infection level of wild-type-transfected cells (shown: mean ± SD; *p < 0.05).
(C) In vitro kinase measurement of HBMECs infected with CVB or PV. Src kinase activity was measured by phosphorylation of Src substrate peptide. Data are
shown as mean ± SD; *p < 0.05.
(D) Shown are HBMECs transfected with PTPN2, PTPRF (LAR), or PTPN18 siRNAs compared to an siRNAwhich had no effect on viral replication. Shown in white
text are the Z score (bottom left) and percent infection (bottom right) from the field displayed. Green, VP1; blue, DAPI.
(E) HBMECs were either pretreated with phosphatase inhibitor IV or inhibitor was added at 3 hr p.i. with CVB or PV. Shown is the level of CVB or PV infection
(mean ± SD; *p < 0.05), normalized to no inhibitor (control) cells.
(F) In vitro phosphatase assay in HBMECs infected with CVB or PV at the indicated times (shown are mean ± SD; *p < 0.05).
See also Table S4.
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of the MAPK signaling pathway as playing roles in restricting
both CVB and PV Infection. CVB infection has been previously
linked to biphasic ERK1/2 activation and in the cleavage of the
upstream regulator of ERK, p21RasGTPase-activating protein
(p21 RasGAP) in HeLa cells (Huber et al., 1999), and enhanced
ERK1/2 activation has been detected in cardiac tissue from
CVB-infected mice (Opavsky et al., 2002). Interestingly, we
also identified p21 RasGAP as a gene whose downregulation
enhanced CVB and PV infection in HBMECs (Figure 2D). Our
findings thus support a model whereby increased ERK1/2 acti-
vation in CVB-infected cells may promote a robust antiviral
immune response.CellWe also identified TLR8 as an important regulator in the
control of CVB and PV replication in HBMECs. TLR8 serves as
a cellular sensor for foreign ssRNA and is localized to endosomal
membranes (Heil et al., 2003, 2004). A role for TLR8 in the detec-
tion of CVB and PV replication in HBMECs is supported by our
identification of IRAK1, which serves a key role in TLR8-medi-
ated signal propagation (Uematsu et al., 2005). TLR8 has also
been shown to play an important role in neuronal functioning
and innate immune signaling in the brain (Ma et al., 2006).
Furthermore, our findings are consistent with a previous study
suggesting that CVB RNA might be detected by TLR8 within
endosomal compartments in cardiac tissue (Triantafilou et al.,
2005). Our identification of TLR8 and associated signalingHost & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inc. 79
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in limiting CVB and PV replication within the BBB.
We also identified 46 genes that were required for infection
of both CVB and PV. This included a pathway whereby infec-
tion induced ADCY-dependent cAMP generation and subse-
quent CREB-mediated transcription to facilitate CVB and PV
replication. Our data indicate that ADCY-dependent cAMP
generation occurs within 2 hr p.i. (Figure 3D) and correlates
with the activation of CREB (Figure 4C). As DDA loses its inhib-
itory effects early in infection (2–3 hr p.i.), these data support
a role for CREB-mediatedtranscription early in infection.
Recently, a role for CREB-mediated upregulation of an innate
immune-associated microRNA (miR-132) has been shown to
facilitate Kaposi’s sarcoma-associated herpesvirus infection
of lymphatic endothelial cells (Lagos et al., 2010). Our data
might support a role for the early induction of CREB-generated
microRNAs in the regulation of CVB and PV infection in the
BBB.
While these data suggest a transcriptional response that facil-
itates infection it is somewhat surprising since it has been estab-
lished that enteroviruses shut down host cellular transcription
machinery during infection. These viruses accomplish this by
expressing a virally encoded enterovirus protease 3Cpro that
cleaves several transcription factors including CREB (Yalaman-
chili et al., 1997) at late stages of infection (>3–4 hr p.i.). The
reduction in CREB levels has been shown in CVB-infected
cardiac tissue in vivo (Yang et al., 1999) and in PV-infected cells
in culture (Kliewer et al., 1990; Yalamanchili et al., 1997). Consis-
tent with this, we found that at later time points during infection of
HBMECs by CVB or PV CREB levels were reduced. Altogether,
our screen identified a role for this signaling pathway in facili-
tating enterovirus infection.
After endocytosis, virus-containing vesicles must navigate
through a complex network of endosomal compartments in
order to gain access to deeper sites within the cytoplasm. In
polarized cells, the endosomal trafficking system is under tight
regulation by a number of cellular components and perturbations
of these components may prevent viruses from accessing sites
of uncoating, thus trapping viral particles at various stages of
the endosomal pathway. We identified several host factors
involved in the regulation of CVB and PV endosomal trafficking
in HBMECs. LMTK2, regulated the trafficking of both CVB and
PV, while Rab17 was specifically required for CVB trafficking.
Both genes were only required in HBMECs as LMTK2 and
Rab17 were dispensable in polarized epithelial Caco-2 cells.
These results suggest that CVB and PV entry into HBMECs
occurs by distinct mechanism from that in Caco-2 cells and indi-
cates that viral entry into polarized cell types is a complex
process that likely requires specialized host factors.
Previously, we found that CVB andPV entry into polarized cells
requires the specific activation of tyrosine kinases and phospha-
tases (Coyne and Bergelson, 2006; Coyne et al., 2007a, 2007b).
At a minimum, these signals are essential for the reorganization
of the cortical actin network, modulation of tight junction barrier
function, and stimulation of viral endocytosis. Our RNAi
screening results indicate that Src family kinases play an impor-
tant role in mediating CVB and PV infection of HBMECs utilizing
distinct members of the SFK family (Yes kinase for CVB and
Lyn kinase for PV) to promote their infection. In addition, our80 Cell Host & Microbe 9, 70–82, January 20, 2011 ª2011 Elsevier Inscreening results highlight the role of protein tyrosine phospha-
tases in regulating infection of CVB and PV as we identified
both common (PTPN2) and unique genes (PTPRF, PTPN18)
that regulated infection. The specificity of the kinases and phos-
phatases involved in infection likely arise from differences in the
signals initiated by receptor binding and highlights the unique
intracellular signalingmolecules involved in regulating viral infec-
tions, even within the same family of viruses.
Within the gene set identified as required for the infection
of CVB, there was an enrichment of factors involved in the regu-
lation of intracellular Ca2+ (Cai
2+) signaling and factors that
directly depend on elevated Cai
2+ levels for their activation (Fig-
ure S5). We identified components involved in multiple stages of
Cai
2+ signaling including genes associated with the release of
Ca2+ from ER-derived stores (ITPR1), Ca2+-dependent cellular
components (CAPN2, CAPN13), and the return of Cai
2+ to resting
basal levels (ATP2B1). Recently, we found that CVB requires the
induction of Cai
2+ to facilitate its entry into HBMECs (Bozym
et al., 2010). The additional genes identified in the current study
expand our understanding of the host factors involved in this
calcium-dependent step in the virus lifecycle.
Polarized cell layers are common sites of virus entry. In partic-
ular, enteroviruses are adept at infecting polarized cells and
have therefore developed efficient strategies to exploit the
epithelial and endothelial barrier. The molecules identified in
this study may represent therapeutic targets of the endothelium
toward a class of pathogens for which there are no effective
therapeutics.
EXPERIMENTAL PROCEDURES
Cells and Viruses
HBMECs and Caco-2 cells were cultured as described previously (Coyne and
Bergelson, 2006; Coyne et al., 2007a). Primary HBMECs were isolated and
cultured as described (Stins et al., 2001). All experiments were performed
with CVB3-RD or PV Sabin 2, as described. Experiments measuring produc-
tive virus infection were performed with 3 PFU/cell (CVB) or 1 PFU/cell (PV)
for approximately 14 hr. For virus entry assays, both CVB and PV were used
at 50–100 PFU/cell.
Antibodies
Mouse anti-enterovirus VP1 (Ncl-Entero) was obtained fromNovocastra Labo-
ratories (New Castle upon Tyne, UK). Goat anti-EEA1, rabbit anti-LMTK2,
GAPDH were from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-
Rab5, anti-Akt2, and CREB pSer133 and mouse anti-CREB were from Cell
Signaling Technologies. Alexa fluor-conjugated secondary antibodies were
from Invitrogen (Carlsbad, CA).
High-Throughput RNAi Screening
Pooled siRNAs (three sites/target, 25 nM final concentration; Ambion Silencer
Library catalog number 81843, set ID 81990) or single siRNAs (three/gene,
25 nM final concentration, QIAGEN) spotted in collagen-coated 384-well
plates were complexed with HiPerfect (0.5 mL/well in 9.5 ml OptiMem). For
a full list of siRNA sequences of validated genes, see Table S1, part D. After
complexing, HBMECs (4000 cells/well, cultured as described [Coyne et al.,
2007a; Stins et al., 2001]) were added to each well 48 hr later infected with
either Coxsackievirus B3 (3 PFU/cell) or Poliovirus Sabin 2 (1 PFU/cell) for
14 hr (Coyne and Bergelson, 2006; Coyne et al., 2007a). Cells were then fixed
with methanol/acetone (3:1), washed, incubated with monoclonal anti-VP1,
washed, and incubated with Alexa Fluor 488-conjugated secondary antibody
in PBS containing 40,6-diamidino-2-phenylindole (DAPI). All solutions were
added with an automated liquid handling (Well-mate, Thermo Fisher) to limit
well-to-well variability.c.
Cell Host & Microbe
Host Factors Regulating Enterovirus InfectionsHigh-Content Image Capturing and Data Analysis
Images were captured (three sites/well) at 103 using an ImageXpressMicro
Microscope (Molecular Devices). Automated image analysis (MetaXpress)
was used to calculate the number of cells (Dapi+) and the number of infected
cells (VP1+). These values were used to calculate the median and interquartile
range (on log transformed data), which were then used to calculate robust
Z scores. (The median of each plate in the screen was used to calculate
baseline.) Hits were identified as those wells that exhibited a change in infec-
tion by the indicated standard deviations from calculated Z scores within each
plate.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and four tables and can be
found with this article online at doi:10.1016/j.chom.2011.01.001.
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